Wolfe Research lowers Honeywell stock price target on aerospace weakness By Investing.com

The market is starting to price HON less as a steady industrial compounder and more as a messy transition story: near-term guidance misses, a temporary geopolitics hit to Process, and execution friction around aerospace supply chains are outweighing the longer-dated spin benefits. The key second-order effect is that a weaker Honeywell near term can actually improve the relative appeal of the post-spin pieces, because investors will eventually separate stranded-cost noise from core automation and aerospace earnings power. That said, the timing matters: the next 1-2 quarters are likely to be dominated by margin pressure and estimate cuts, so multiple expansion is hard to justify until the market sees cleaner standalone reporting.

The most important hidden variable is aerospace recovery quality, not just volume. If production ramps while supply constraints persist, HON can show top-line improvement without full margin leverage, which tends to disappoint a stock already de-rated on expectations of faster expansion. In other words, the path to upside is delayed by 2-3 quarters unless supplier bottlenecks clear faster than management is signaling; if they do, the surprise could be meaningful because backlog provides operating leverage once conversion normalizes.

The contrarian angle is that the spin and asset monetization optionality may be underappreciated in a risk-off tape. A cleaner automation company plus embedded value from Quantinuum/pension surplus creates a floor that could become visible once the market stops anchoring on the legacy consolidated EPS. The better way to express the view is likely relative value: HON can underperform on headline guide cuts while still being attractive versus lower-quality industrials with less balance-sheet optionality and no breakup catalyst.